Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04134637
Other study ID # D178
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2019
Est. completion date December 1, 2020

Study information

Verified date December 2020
Source Fayoum University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective is to test the effect of pecto intercostal fascial plane block (PIFB) as regard its impact on pain after sternotomy involved open heart surgery. The authors hypothesize that bilateral PIFB can reduce pain resulting from sternotomy following open heart surgeries.


Description:

Pain following cardiac surgery is caused by many factors; sternotomy, chest wall retraction, opening of the pericardium, internal mammarian artery harvesting, saphenous vein harvesting, surgical manipulation of the parietal pleura, chest tube insertion and other musculoskeletal trauma occurring during surgery. The pain following cardiac surgery is mainly attributed to sternotomy, with its peak during the first two days after the operation. Poststernotomy pain is not well tolerated by patients and may be accompanied by adverse postoperative events including delirium, hypertension, tachycardia, arrhythmia, respiratory complications, and persistent postsurgical pain. Commonly pain management after cardiac surgery has been achieved using opiate analgesics. However, opiates have some dose-related side-effects such as nausea, constipation, vomiting, dizziness, mental confusion and respiratory depression, which may influence patient recovery and may delay discharge after surgery. The pecto-intercostal fascial block (PIFB) was recently introduced by de la Torre et al for anesthesia during breast surgery. Local anesthetic is infiltrated into the interfascial plane separating pectoralis major and the intercostal muscles lateral to the sternum to anesthetize the anterior cutaneous branches of the intercostal nerves. The pecto-intercostal fascial plane block can cover anterior branches of the intercostal nerves from the 2nd to 6th dermatomes with a single injection bilaterally, same as the transversus thoracic muscle plane block . anesthetic management: All patients will be preoperatively examined and investigated by complete blood count, coagulation profile, renal and kidney functions and electrolytes. Electrocardiography, chest x ray and echocardiography will be routinely done. Coronary angiography and carotid arterial duplex will be requested in patients prepared for CABG. Patient will be premedicated by intramuscular injection of 10mg morphine in the morning of the operation. Before induction of anesthesia, a five-lead electrocardiography system will be applied to monitor heart rate, rhythm, and ST segments (leads II and V5). A pulse oximeter probe will be attached, and a peripheral venous cannula will be placed. For measurement of arterial pressure and blood sampling, a 20 G cannula will be inserted into either right or left radial artery under local anesthesia. General anesthesia will be induced by midazolam 2-5 mg, fentanyl (10 μg/kg), propofol (3-4mg/Kg), followed by atracurium (0.5 mg/kg). Trachea will be intubated, patients will be mechanically ventilated with oxygen in air so as to achieve normocarbia. This will be confirmed by radial arterial blood gas analysis. An esophageal temperature probe and a Foley catheter will also be placed. For drug infusion, a triple-lumen central venous catheter will be inserted via the right internal jugular vein. Anesthesia will be maintained by inhaled Isoflurane 0.4 to 1% and atracurium infusion at a rate of 0.5 mg/kg/h for continued muscle relaxation. During extracorporeal circulation, patients will receive propofol infusion at a rate of 100-200 mg/h in addition to atracurium infusion. Before initiation of cardiopulmonary bypass (CPB), the patients will receive intravenously tranexamic acid (2 g) and heparin (300-500 units/kg body weight) to achieve an activated clotting time > 480 s. CPB will be instituted via an ascending aortic cannula and a two-stage right atrial cannula. Before, during, and after CPB (pump blood flow: 2.4 l/min/m2), mean arterial pressure will be adjusted to exceed 60 mmHg. Cardiac arrest will be induced with cold antegrade blood cardioplegia or warm intermittent antegrade crystalloid cardioplegia. Lactate-enriched Ringer's solution will be added to the CPB circuit to maintain reservoir volume when needed, and packed red blood cells will be added when hemoglobin concentration decrease to less than 7 g/dl. After rewarming the patient to 37°C and separation from CPB, reversal of heparin by protamine sulfate (1:1), and sternal closure will be achieved. All patients then will be shifted to the intensive care unit (ICU) after the surgery and managed with the institution's ICU protocol for postoperative pain management and ventilation. The postoperative analgesia protocol involves the use of intravenous morphine or morphine equivalent dose of 5to 10 mg/kg bolus as required. Criteria for administration will be signs of sympathetic stimulation in the form of undue tachycardia, a rise in mean arterial pressure (rise of >20% from the baseline). Tracheal extubation will be performed when the patient met the following criteria: awake/arousable, hemodynamically stable, no active bleeding, warm peripheries, and satisfactory arterial blood gas with an FiO2 < 0.5,pressure support on ventilator reduced to 10 Cm H2O,Positive End Expiratory Pressure 5-7 CmH2O, no electrolyte abnormalities, minimal inotropic support, or no escalation in inotropic support. Statistical analysis Sample size was calculated using (G power version 3). Minimal sample size of patients was 31 in each group needed to get power level 0.90, alpha level 0.05 and 30% as a difference between the two groups in the morphine consumption after the intervention. To overcome problem of loss of follow up, calculated sample size was increased by 10% to reach 35 in each group.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date December 1, 2020
Est. primary completion date November 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients scheduled for elective cardiovascular surgery for coronary artery bypass grafting or valve replacement involving median sternotomy Exclusion Criteria: - Patients with emergency surgeries. - Allergy to drug used. - Patients with prolonged Cardio-Pulmonary Bypass time (>120 min). - Preoperative poor left ventricular function (ejection fraction <40%). - Body Mass Index >40. - Systemic infections or infections at site of injection. - Prolonged ICU stay over 24 hours for different reasons i.e.re-do surgery, heart failure etc.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ultrasound
in the PIFB group linear ultrasound (Philips clear vue350,Philips healthcare,Andover MAO1810,USA,Machine Identification number:1385,Nile medical center,service@nilemed.net) probe will be used.
Drug:
Bupivacaine Hydrochloride 5 MG/ML
twenty milliliters of a solution of 0.25% bupivacaine in the PIFB group

Locations

Country Name City State
Egypt Fayoum university hospital Fayoum

Sponsors (1)

Lead Sponsor Collaborator
Fayoum University Hospital

Country where clinical trial is conducted

Egypt, 

References & Publications (5)

Chandrakantan A, Glass PS. Multimodal therapies for postoperative nausea and vomiting, and pain. Br J Anaesth. 2011 Dec;107 Suppl 1:i27-40. doi: 10.1093/bja/aer358. — View Citation

Del Buono R, Costa F, Agrò FE. Parasternal, Pecto-intercostal, Pecs, and Transverse Thoracic Muscle Plane Blocks: A Rose by Any Other Name Would Smell as Sweet. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):791-792. — View Citation

Huang AP, Sakata RK. [Pain after sternotomy - review]. Rev Bras Anestesiol. 2016 Jul-Aug;66(4):395-401. doi: 10.1016/j.bjan.2014.09.003. Epub 2015 Mar 18. Portuguese. — View Citation

Mazzeffi M, Khelemsky Y. Poststernotomy pain: a clinical review. J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1163-78. doi: 10.1053/j.jvca.2011.08.001. Epub 2011 Sep 29. Review. — View Citation

Ohgoshi Y, Ino K, Matsukawa M. Ultrasound-guided parasternal intercostal nerve block. J Anesth. 2016 Oct;30(5):916. doi: 10.1007/s00540-016-2202-5. Epub 2016 Jun 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Age in years 2 hours before operation
Other body mass index kilogram/square meter 2 hours before operation
Primary Cumulative morphine consumption in milligram 24 hours postoperative
Secondary postoperative sternal wound pain degree Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing
1 (worst) to 4 (best) not summed
4 hours after extubation
Secondary postoperative sternal wound pain degree Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing
1 (worst) to 4 (best) not summed
8 hours after extubation
Secondary postoperative sternal wound pain degree Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing
1 (worst) to 4 (best) not summed
12 hours after extubation
Secondary postoperative sternal wound pain degree Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing
1 (worst) to 4 (best) not summed
16 hours after extubation
Secondary postoperative sternal wound pain degree Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing
1 (worst) to 4 (best) not summed
20 hours after extubation
Secondary postoperative sternal wound pain degree Objective pain score (1:pain at rest , 2:Pain free at rest, 3:Pain free when deep breathing, but pain when coughing, 4:Pain free, even when coughing
1 (worst) to 4 (best) not summed
24 hours after extubation
Secondary Heart rate in beat per minute 1 minute before induction of anesthesia, 5 minutes after induction of anesthesia then every 30 minutes for 8 times
Secondary systolic blood pressure in millimeter mercury 1 minute before induction of anesthesia, 5 minutes after induction of anesthesia then every 30 minutes for 8 times
Secondary diastolic blood pressure in millimeter mercury 1 minute before induction of anesthesia, 5 minutes after induction of anesthesia then every 30 minutes for 8 times
Secondary peripheral oxygen saturation in percentage by pulse oximetry 1 minute before induction of anesthesia, 5 minutes after induction of anesthesia then every 30 minutes for 8 times
Secondary heart rate in beat per minute 1 minute after admission in ICU then every 4 hours for 6 times then every 8 hours for 3 times
Secondary systolic blood pressure in millimeter mercury 1 minute after admission in ICU then every 4 hours for 6 times then every 8 hours for 3 times
Secondary diastolic blood pressure in millimeter mercury 1 minute after admission in ICU then every 4 hours for 6 times then every 8 hours for 3 times
Secondary peripheral oxygen saturation in percentage by pulse oximetry 1 minute after admission in ICU then every 4 hours for 6 times then every 8 hours for 3 times
Secondary incidence of Myocardial infarction number 1 minute after ICU admission
Secondary incidence of postoperative pericardial effusion number 1 minute after ICU admission
Secondary incidence of heart failure requiring inotropic support number 1 minute after ICU admission
Secondary incidence of atrial fibrillation number 1 minute after ICU admission
Secondary partial pressure of oxygen by mmhg in arterial blood gases 1 minute after insertion of arterial cannula
Secondary partial pressure of oxygen by mmhg in arterial blood gases 1 minute after extubation
Secondary partial pressure of oxygen by mmhg in arterial blood gases 6 hour after extubation
Secondary partial pressure of oxygen by mmhg in arterial blood gases 12 hour after extubation
Secondary incidence of cerebral stroke number 1 minute after ICU admission up to 2 days
Secondary incidence of cerebral bleeding number 1 minute after ICU admission up to 2 days
Secondary Gastrointestinal bleeding number 1 minute after ICU admission up to 2 days
Secondary blood component requirements number 1 minute after ICU admission up to 2 days
Secondary incidence of sternal complications. number 1 minute after ICU admission up to 2 days
Secondary hospital stay in days 1 minute after ICU admission up to 2 days
See also
  Status Clinical Trial Phase
Recruiting NCT06243718 - Phrenic Nerve Reconstruction for the Treatment of Diaphragmatic Paralysis: Patient Experiences and Reported Outcomes.
Completed NCT04094532 - Transversus Thoracic Muscle Plane Block for Open Heart Surgery N/A
Active, not recruiting NCT05283980 - Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement Phase 2/Phase 3
Recruiting NCT03770208 - RIB PAIN (Rib Fractures Treated With Parental Analgesia With Infused LidocaiNe) N/A
Withdrawn NCT03961048 - Ideal Initial Bolus and Infusion Rate for Erector Spinae Plane Block Catheters Phase 4
Withdrawn NCT03874806 - Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block Phase 4
Not yet recruiting NCT05204043 - Peter Hess® Sound Massage for Reducing Anxiety and Pain in Cardiac Surgery N/A
Recruiting NCT04080934 - Breaststroke Swimming After Breast Cancer Treatment/Surgery as a Means of Treatment for Seroma, Lymphedema, and Chronic Arm and Chest Pain N/A
Completed NCT04715932 - Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) Phase 2
Not yet recruiting NCT06222320 - Kinesiotaping Method for Rib Fractures Phase 2/Phase 3